These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 3567926)

  • 21. Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide.
    D'Incalci M; Torti L; Damia G; Erba E; Morasca L; Garattini S
    Cancer Res; 1983 Dec; 43(12 Pt 1):5674-80. PubMed ID: 6357429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of N,N'-bis(2-chloroethyl)-N-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-2-deoxy-D-glucopyranose upon the proliferation, DNA synthesis, and viability of cultured sensitive and resistant L1210 cells.
    Wheeler GP; Alexander JA; Adamson DJ
    Cancer Res; 1980 Oct; 40(10):3723-7. PubMed ID: 6449283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
    Roboz J; Jiang J; Holland JF; Bekesi JG
    Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents.
    Friedman HS; Colvin OM; Skapek SX; Ludeman SM; Elion GB; Schold SC; Jacobsen PF; Muhlbaier LH; Bigner DD
    Cancer Res; 1988 Aug; 48(15):4189-95. PubMed ID: 3390813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R; Khokhar AR; Lopez-Berestein G
    Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA synthesis, protein synthesis and platinum content following drug administration in cis-diamminedichloroplatinum(II) -sensitive and -resistant L1210 cells transferred from in vitro to in vivo conditions.
    Hanusovská E; Ujházy V
    Neoplasma; 1987; 34(6):721-6. PubMed ID: 3431611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo DNA damage and resistance to 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in L1210 leukemia cells.
    Gorbacheva LB; Kukushkina GV; Durdeva AD; Ponomarenko NA
    Neoplasma; 1988; 35(1):3-14. PubMed ID: 3127736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
    Eder JP; Teicher BA; Holden SA; Cathcart KN; Schnipper LE; Frei E
    Cancer Res; 1989 Feb; 49(3):595-8. PubMed ID: 2910481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.
    Hickman JA; Stevens MF; Gibson NW; Langdon SP; Fizames C; Lavelle F; Atassi G; Lunt E; Tilson RM
    Cancer Res; 1985 Jul; 45(7):3008-13. PubMed ID: 4005840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electronic volume analysis of L1210 chemotherapy.
    Zucker RM; Helfman D
    Cancer Res; 1976 Dec; 36(12):4434-8. PubMed ID: 1000492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo.
    Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
    Cancer Chemother Pharmacol; 1990; 25(6):425-9. PubMed ID: 2311170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
    Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP
    Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive values of the in vivo diffusion chamber for cyclophosphamide treatment of L1210 murine leukemia.
    Anderson KC; Humphrey RL; Sensenbrenner LL
    Cancer Res; 1983 May; 43(5):2030-3. PubMed ID: 6831434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
    Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined effects of immunity and antitumor drugs against cancer. I. In vivo studies with cis-diamminedichloroplatinum and cyclophosphamide in mouse models.
    Ricci F; De Filippi R; Riccardi C; Romani L; Giuliani A
    Chemioterapia; 1987 Dec; 6(6):403-9. PubMed ID: 3435922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
    Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
    Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
    Hill RP; Stanley JA
    Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Rosenblum ML; Wheeler KT; Wilson CB; Barker M; Knebel KD
    Cancer Res; 1975 Jun; 35(6):1387-91. PubMed ID: 1131813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.